Rush sublingual immunotherapy in parietaria allergic patients

Allergologia et Immunopathologia

Volumn 24, Issue 4, 1996, Pages 146-151

  Purello D'Ambrosio, F ^a   Ricciardi, L ^a   Isola, S ^a   Puccinellia, P ^b   Musarra, A ^a   Parmiani, Silvano ^c  

^a UNIVERSITY OF MESSINA   (Italy)

^b Neo Abello' Ospiate di Bollate   (Italy)

^c Neo Abellò ^*  (Italy)

Author keywords

compliance; efficacy; Parietaria pollen; rhinoconjunctivitis; rush sublingual immunotherapy; safety

Indexed keywords

PARIETARIA JUDAICA EXTRACT; PLANT EXTRACT; POLLEN ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ALLERGIC ASTHMA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; IMMUNOTHERAPY; MALE; PATIENT COMPLIANCE; POLLEN ALLERGY; RANDOMIZED CONTROLLED TRIAL; RHINOCONJUNCTIVITIS; SENSITIZATION; SUBLINGUAL DRUG ADMINISTRATION; SYMPTOMATOLOGY;

ADMINISTRATION, SUBLINGUAL; ADOLESCENT; ADULT; AGED; ALLERGENS; ASTHMA; CONJUNCTIVITIS, ALLERGIC; DESENSITIZATION, IMMUNOLOGIC; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; PLANT EXTRACTS; POLLEN; RHINITIS, ALLERGIC, SEASONAL; SEASONS; TREATMENT OUTCOME;

EID: 0029955038     PISSN: 03010546     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. D'Amato G. and Lobefalo G. Allergenic pollens in the Mediterranean area J Allergy Clin Immunol 1989, 83: 116-122.
2. D'Amato G and Melillo G. Le aerospore di importanza allergenica in Italia. Atti XVI Congr Soc It Allergol Immunol Clin Leonardo, Roma, 1983, 291-303.
3. D'Amato G and Melillo G. Pollinosis in Italy Ann Allergy 1985; 55: 246.
4. Negrini A.C Pollinosis in Italy In: Proceedings of Int Symp Pollinosis in the Mediterranean Area. R. Curto, Naples, 1989; 39-44.
5. Malling H.J. and Weeke B. Revised EAACI Position Paper on Immunotherapy. Allergy 1993; 48: S14.
6. Bousquet J. and Michel F.B. Sub-cutaneous and local specific immunotherapy in perspective In: Proceedings of the XVI European Congress of Allergology and Clinical Immunology Ed. Basomba A., Sastre J - Vol. I - Monduzzi Editore S.p.A. Bologna, Italy, 1995: 717-722
7. Ortolani C., Pastorello E.A., Incorvaia C., Ispano M., Farioli L., Zara C., Pravettoni V. and Zanussi C A double-blind, placebo controlled study of immunotherapy with an alginate-conjugated extract of Parietaria judaica in patients with Parietaria hay fever. Allergy 1994; 49 (1): 13-21
8. D'Amato G., Kordash T.R., Liccardi G , Lobefalo G., Cazzola M. and Freshwater L.L Immunotherapy with Alpare in patients with respiratory allergy to Parietaria pollen: a two year double-Wind placebo-controlled study Clin Exp Allergy 1995; 25: 149-158.
9. Rudd S. Immunotherapy compliance - a shot in the dark. Ann Allergy Asthma Immunol 1995; 74: 195-198.
10. Van Niekerk C.H. and De Wet J I. Efficacy of grass-maize pollen oral immunotherapy in patients with seasonal hay fever: a double blind study. Clin All 1987; 17: 507-511.
11. Tari M.G., Mancino M. and Monti G. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double-blind study. Allergol Immunopathol Madr 1990; 18: 277-284
12. Xiao L , Yang-Xin F , Shi-Tai Y and Shu-Quing D. A double blind trial of oral immunotherapy for Artemisia pollen asthma with evaluation of bronchial response to the pollen allergen and serum specific IgE antibody. Ann All 1990; 64: 27-31
13. Crimi E , Voltolini S., Troise C. et al. Local immunotherapy with Dermatophagoides extract in asthma. J Allergy Clin Immunol 1991; 87: 721-728.
14. Moscato G., Rossi G., Dellabianca A., Pisati A , Vinci B and Biale C. Local immunotherapy by inhalation of a powder extract in asthma due to house dust mite Dermatophagoides pteronyssinus: a double blind comparison with parenteral immunotherapy. J Investig Allergol Clin Immunol 1991, 1: 383-394.
15. Andri L., Senna G.E., Betteli C., Givanni S., Andri G., Falagiani P. and Lugo G. Local nasal immunotherapy in allergic rhinitis to Parietaria. A double-blind controlled study Allergy 1992; 47 (4 Pt 1): 318-323
16. Taudorf E. Oral immunotherapy of adults with allergic rhinoconjunctivitis. Clinical effects in birch and grass pollinosis. Dan Med Bull 1992; 39: 542-560.
17. Feliziani V., Marfisi R.M. and Parmiani S Rush immunotherapy with sublingual administration of grass pollen extract Allergol Immunopathol 1993; 21 (5) 173-178.
18. Giovane A.L., Bardare M., Passalacqua G., Ruffoni S., Scordamaglia A., Ghezzi E. and Canonica G.W. A three-year double-blind placebo-controlled study with specific oral immunotherapy to Dermatophagoides: evidence of safety and efficacy in pediatric patients. Clin Exp All 1994; 24: 53-59
19. D'Amato G., Lobefalo G., Liccardi G. and Cazzola M. A doubleblind placebo-controlled trial of local nasal immunotherapy in allergic rhinitis to Parietaria pollen Clin Exp Allergy 1995; 25: 141-148.
20. Sabbah A., Hassoun S , Le-Sellin J. André C and Sicard H. A double-blind placebo-controlled trial by the sublingual route of immunotherapy with a standardized grass pollen extract Allergy 1994, 49: 309-313.
21. Troise C., Voltolini S., Canessa A , Pecora S., and Negrini A.C. Sublingual immunotherapy in Parietaria pollen-induced rhinitis: A double blind study J Invest Allergol Clin Immunol 1995; 5(1): 25-30.
22. Scadding G and Brostoff J. Low dose sublingual therapy in patients with allergic rhinitis due to house dust mite Clin Allergy 1986; 16: 493-499.
23. Nelson H., Oppenheimer J., Vatsia G. and Buchmeier A A double-blind placebo-controlled evaluation of sublingual immunotherapy with standardized cat extract. J All Clin Immunol 1993; 92 229-236.
24. Rebien W , Puttonen E., Maasch H.J , Stix E. and Wahn U Clinical and immunological response to oral and subcutaneous immunotherapy with grass pollen extracts. A prospective study. Eur J Pediatr 1982, 138: 341-344.
25. Cooper P J., Darbyshire J , Nunn A.J. and Warner J.O. A controlled trial of oral hyposensitization in pollen asthma and rhinitis in children. Clin Allergy 1984; 14: 541-550.
26. Taudorf E , Laursen L., Djurup R et al. Oral administration of grass pollen to hay fever patients. An efficacy study of oral hyposensitization. Allergy 195; 40: 321-325.
27. Oppenheimer J., Areson J.G., and Nelson H S. Safety and efficacy of oral immunotherapy with standardized cat extract. J Allergy Clin Immunol 1994; 93: 61-67.
28. Welsh P W., Butterfield J.H , Yunginger J.W , Agarwal M.K. and Gleich G J. Allergen controlled study of intranasal immunotherapy for ragweed hay fever. J Allergy Clin Immunol 1983, 71: 454-460
29. Commissione S.I.A.I.C. (Errigo E., Canonica G.W , Corsico R., Negrini C.A., Ortolani C , Tursi A., Pastorello E.A.). Position Statement "Memorandum" sull'immunoterapia specifica - Edizione 1991 Giorn It Allergol Immunol Clin 1991, 1: 99-114.
30. Brighton W B , Topping M D. and Henocq E. Activity units for allergen extracts. Clin Allergy 1979; 9: 591-596.
31. Carreira J , Rubio M., Herrero T , Horak F., Businco L , Wuthrich B , Bearzi De Prada V., Berry J.B., Lischka G. and Brighton W D. Collaborative clinical assay of the biological potency of allergen skin-test extracts. Clin Allergy 1984; 14: 503-507.
32. Ayuso R., Carreira J , Lombardero M., Duffort O., Peris A., Basomba A. and Polo F. Isolation by mAb based affinity chromatography of two Par j 1 isoallergens. Comparison of their physiochemical, immunochemical and allergenic properties Mol Immunol 1993; 30 11347-11354.
33. Bjorksten B , Dreborg S., Lanner A. and Moller C Oral immunotherapy of children with rhinoconjunctivitis due to birch pollen allergy. Allergy 1986; 41: 271-279